PROPOFOL (Hospira, Inc.)


Welcome to the PulseAid listing for the PROPOFOL drug offered from Hospira, Inc.. This General Anesthesia [PE],General Anesthetic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: PROPOFOL
SUBSTANCE NAME: PROPOFOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: General Anesthesia [PE],General Anesthetic [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, EMULSION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2006-04-03
END MARKETING DATE: 0000-00-00


PROPOFOL HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPROPOFOL from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2006-04-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-4699_2479b268-34ce-493b-aa23-ebfe27d922aa
PRODUCT NDC: 0409-4699
APPLICATION NUMBER: ANDA077908

Other PROPOFOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Propofol
APP Pharmaceuticals, LLCPropofol
Fresenius Kabi USA, LLCDiprivan
General Injectables & Vaccines, IncDiprivan
General Injectables and Vaccines, IncPropofol
Hospira, Inc.PROPOFOL
Sagent Pharmaceuticalspropofol